Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade

ABSTRACTIn preclinical in vivo models of cancer, the induction of immunogenic cell death (ICD) sensitizes to subsequent immunotherapy. Several clinical trials now confirm that pretreatment with ICD...